Cigna Corp. (CI) Shareholder Friess Associates LLC Has Boosted Position by $3.53 Million

February 15, 2018 - By Kurt Siggers

Investors sentiment is 0.96 in Q3 2017. Its the same as in 2017Q2. It has no change, as 47 investors sold CI shares while 249 reduced holdings. only 72 funds opened positions while 212 raised stakes. 206.32 million shares or 5.35% less from 217.98 million shares in 2017Q2 were reported. Umb National Bank N A Mo invested in 10,853 shares. Samlyn Cap Limited Liability Corp holds 1.37% of its portfolio in Cigna Corporation (NYSE:CI) for 289,432 shares. The Illinois-based Northern Tru Corporation has invested 0.15% in Cigna Corporation (NYSE:CI). Moreover, Employees Retirement Of Texas has 0.16% invested in Cigna Corporation (NYSE:CI). Exxonmobil Investment Tx invested in 45,978 shares. Korea Inv Corp has invested 0.13% in Cigna Corporation (NYSE:CI). Oppenheimer Asset Mgmt, New York-based fund reported 1,314 shares. Axa reported 220,462 shares or 0.18% of all its holdings. Chatham Capital Group holds 0.12% of its portfolio in Cigna Corporation (NYSE:CI) for 2,281 shares. Proshare Ltd Limited Liability Company holds 28,562 shares. The Ontario – Canada-based Intact Inv Mngmt has invested 0.02% in Cigna Corporation (NYSE:CI). Pillar Pacific Mgmt Ltd Company has invested 0.09% in Cigna Corporation (NYSE:CI). Chicago Equity Prtn Ltd Liability Company invested in 0.01% or 2,390 shares. Parkside Bankshares Tru invested in 115 shares. Jennison Associate Ltd stated it has 0.25% of its portfolio in Cigna Corporation (NYSE:CI).

Since August 16, 2017, it had 0 insider purchases, and 8 insider sales for $8.84 million activity. ZOLLARS WILLIAM D had sold 1,232 shares worth $230,662. Another trade for 400 shares valued at $85,184 was sold by HENNEY JANE E MD. MURABITO JOHN M had sold 6,099 shares worth $1.34M on Thursday, January 18. $1.29M worth of Cigna Corporation (NYSE:CI) shares were sold by ZARCONE DONNA F. On Wednesday, August 16 the insider Bacus Lisa R sold $402,366.

Friess Associates Llc increased its stake in Cigna Corp. (CI) by 23.65% based on its latest 2017Q3 regulatory filing with the SEC. Friess Associates Llc bought 19,000 shares as the company’s stock rose 11.09% with the market. The institutional investor held 99,324 shares of the medical specialities company at the end of 2017Q3, valued at $18.57 million, up from 80,324 at the end of the previous reported quarter. Friess Associates Llc who had been investing in Cigna Corp. for a number of months, seems to be bullish on the $46.72B market cap company. The stock decreased 2.08% or $4.07 during the last trading session, reaching $191.48. About 1.20M shares traded. Cigna Corporation (NYSE:CI) has risen 23.57% since February 15, 2017 and is uptrending. It has outperformed by 6.87% the S&P500.

Another recent and important Cigna Corporation (NYSE:CI) news was published by Businesswire.com which published an article titled: “Cigna Increases Minimum Wage to $16 an Hour and Further Accelerates …” on January 31, 2018.

Cigna Corporation (NYSE:CI) Ratings Coverage

Among 20 analysts covering CIGNA (NYSE:CI), 16 have Buy rating, 0 Sell and 4 Hold. Therefore 80% are positive. CIGNA had 59 analyst reports since July 27, 2015 according to SRatingsIntel. Morgan Stanley maintained it with “Overweight” rating and $195 target in Thursday, August 17 report. RBC Capital Markets maintained the stock with “Buy” rating in Monday, August 7 report. As per Wednesday, August 5, the company rating was downgraded by Zacks. Morgan Stanley initiated the shares of CI in report on Wednesday, June 7 with “Overweight” rating. Deutsche Bank maintained Cigna Corporation (NYSE:CI) on Monday, August 7 with “Buy” rating. Leerink Swann maintained the stock with “Buy” rating in Friday, February 2 report. The rating was maintained by Barclays Capital on Wednesday, January 6 with “Equal-Weight”. UBS maintained Cigna Corporation (NYSE:CI) rating on Monday, June 5. UBS has “Buy” rating and $18600 target. The stock of Cigna Corporation (NYSE:CI) earned “Buy” rating by Cowen & Co on Thursday, July 13. The firm has “Buy” rating by Jefferies given on Friday, January 8.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.